I've been reading and trying to understand about what they are trying to achieve.....interestingly their conclusions on the feasibility and safety looks good IMO :)
1. Feasibility - Multinational manufacture and distribution of
CVac was possible
2. Safe - CVac was well tolerated with minimal toxicity
3. Immunogenic - Positive mucin 1-specific T cell response in
CVac treated patients
4. PFS signal in second remission
5. Interim OS signal in second remission
overall survival chart is beautifull, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.055(18.6%) |
Mkt cap ! $504.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $5.406M | 15.14M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 156850 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 341991 | 9 |
View Market Depth
| Last trade - 14.03pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |